Theratechnologies CEO retires; Amorfix’s steps down
June 2, 2010 by leonardzehr · Leave a Comment
Yves Rosconi, CEO and President of Theratechnologies (TSX:TH), has informed the board of his decision to retire on Dec. 31, 2010, saying he deferred his decision until the company’s lead tesamorelin product was in the final stages of the FDA approval process. A strategic committee of the board will immediately begin the formal search for [...]
Listen to BioTuesdays 
